Clinical Trials for Anal Cancer

Find clinical trials for anal cancer. Discover research opportunities and treatment options in your area.

42 Active Trials Found

Showing 42 trials on this page

Page 2 of 3

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

NCT ID: NCT04907643

This clinical trial is exploring how virtual reality (VR) can help manage severe abdominal pain in patients with digestive tract cancers. The study aims to find out if using immersive VR—where pati...

Recruiting

Phase: NA Type: interventional Locations: Los Angeles, California, United States

Enhanced Assistance During Radiotherapy for Unmet Essential Needs

NCT ID: NCT06582849

This clinical trial is exploring how providing extra support can help patients with certain cancers complete their radiotherapy treatments without delays. Radiotherapy is a common treatment that us...

Recruiting

Phase: NA Type: interventional Locations: Saint Louis, Missouri, United States

HPV Infection and Vaginal Microecology in Immunosuppressed Women

NCT ID: NCT06619743

This clinical trial is studying the relationship between HPV (a virus that can cause cervical and anal cancer) and the vaginal and intestinal environment in women who are HIV positive. The goal is ...

Not yet recruiting

Type: observational

NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal Cancer

NCT ID: NCT05572801

The NOAC9 trial is looking at how well a new test that checks for circulating tumor DNA (ctDNA) can help doctors find out if treatment for anal cancer is working or if the cancer is coming back aft...

Recruiting

Phase: NA Type: interventional Locations: Aarhus, , Denmark, Bergen, , Norway +13 more

SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas

NCT ID: NCT06544720

This clinical trial is studying a new treatment called SCG142 TCR-T cells for patients with advanced cancers linked to the human papillomavirus (HPV). These cancers include cervical cancer, head an...

Recruiting

Phase: PHASE1 Type: interventional Locations: Qingdao, Shandong, China

Blood Biomarkers Based Screening for HPV-driven OPC

NCT ID: NCT06528353

This clinical trial is looking at a new way to detect and treat cancers caused by the human papillomavirus (HPV), specifically focusing on oropharyngeal cancers (OPC) that affect the throat. The re...

Not yet recruiting

Phase: NA Type: interventional

Deciphering Mechanisms Underlying Cancer Immunogenicity

NCT ID: NCT03958240

This clinical trial aims to understand how certain cancers react to the immune system by studying a specific protein called PD-1 found in immune cells known as T cells. The trial will involve 900 p...

Recruiting

Phase: NA Type: interventional Locations: Toulouse, , France, Toulouse, , France +1 more

Stigma and Psychological profilE in REctal-anal caNcer pAtients

NCT ID: NCT06366841

This clinical trial is focused on understanding the psychological effects of rectal and anal cancer on patients, particularly how stigma and other psychological factors can impact their well-being....

Recruiting

Type: observational Locations: Roma, , Italy, Roma, , Italy +1 more

CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers

NCT ID: NCT06358053

This clinical trial, called CRTE7A2-01, is exploring a new treatment using specially engineered T cells for patients with advanced cancers that are positive for the HPV-16 virus, such as cervical c...

Not yet recruiting

Phase: PHASE1 Type: interventional

Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens

NCT ID: NCT06327568

This clinical trial is studying a new test called the BD Onclarity™ HPV Assay, which aims to improve screening for anal cancer and precancerous conditions. The test focuses on detecting high-risk s...

Recruiting

Type: observational Locations: Milan, , Italy

HRYZ-T101 Injection for HPV18 Positive Solid Tumor

NCT ID: NCT05952947

This clinical trial is looking at a new treatment called HRYZ-T101 injection for patients with certain types of solid tumors that are caused by a virus known as HPV18. The trial aims to find out ho...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, Shanghai, China, Shanghai, Shanghai, China

Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy

NCT ID: NCT04094454

This clinical trial is studying the effects of using a special vaginal dilator during pelvic radiotherapy for women with anal cancer. The purpose is to see if using this dilator helps reduce the ri...

Recruiting

Phase: NA Type: interventional Locations: Heidelberg, , Germany

Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors

NCT ID: NCT04889742

This clinical trial is studying a new treatment approach for patients with recurrent cancer who have already received radiation therapy in the past. The researchers want to see if using heat (calle...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Berlin, , Germany

ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer

NCT ID: NCT04792892

The ANCA II trial is studying how anal cancer affects the quality of life and everyday functioning of patients. Anal cancer is a rare but increasing condition, and while many patients respond well ...

Recruiting

Type: observational Locations: Gothenburg, , Sweden

Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer

NCT ID: NCT05438836

This clinical trial is studying a new way of giving radiation therapy to patients with anal cancer. The goal is to see if a technique called daily online adaptive radiotherapy can help reduce side ...

Recruiting

Type: observational Locations: Herlev, , Denmark

A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation

NCT ID: NCT04141449

This clinical trial is studying a program called Potlako+, which aims to help people access cancer care more effectively. The trial will compare two groups: one group will receive the Potlako+ prog...

Recruiting

Phase: PHASE2 Type: interventional Locations: Gaborone, , Botswana

Human Papillomavirus in Young People Epidemiological Research 3

NCT ID: NCT05587725

The HYPER3 study is researching how common Human Papillomavirus (HPV) is among young gay and bisexual men aged 16 to 20 years in Australia. This group is particularly at risk for anal cancer, espec...

Recruiting

Type: observational Locations: Melbourne, Victoria, Australia

HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL

NCT ID: NCT03947775

The HPV-SAVE trial is a research study focused on finding better ways to prevent anal cancer and related issues caused by the human papillomavirus (HPV) in men who have sex with men (MSM), especial...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Vancouver, British Columbia, Canada, Toronto, Ontario, Canada +2 more

Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients

NCT ID: NCT05374252

This clinical trial is studying a new treatment approach for patients with locally advanced anal canal squamous carcinoma, a type of anal cancer. Researchers want to find out if adding a medication...

Recruiting

Phase: PHASE3 Type: interventional Locations: Guangzhou, Guangdong, China

Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy

NCT ID: NCT05233540

This clinical trial is studying the use of blood tests to help understand how well patients with anal cancer respond to a specific type of treatment called induction chemotherapy (ICT). The researc...

Recruiting

Type: observational Locations: Aarhus, Aarhus N, Denmark, Herlev, , Denmark +1 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions